Progression of diabetes retinal status within community screening programs and potential implications for screening intervals
Progression of diabetes retinal status within community screening programs and potential implications for screening intervals
Objective: this study aimed to follow the natural progression of retinal changes in patients with diabetes. Such information should inform decisions with regard to the screening intervals for such patients.
Research design and methods: an observational study was undertaken linking the data from seven diabetes retinal screening programs across the U.K. for retinal grading results between 2005 and 2012. Patients with absent or background retinopathy were followed up for progression to the end points referable retinopathy and treatable retinopathy (proliferative retinopathy).
Results: in total, 354,549 patients were observed for up to 4 years during which 16,196 patients progressed to referable retinopathy. Of patients with no retinopathy in either eye for two successive screening episodes at least 12 months apart, the conditions of between 0.3% (95% CI 0.3–0.8%) and 1.3% (1.0–1.6%) of patients progressed to referable retinopathy, and rates of treatable eye disease were <0.3% at 2 years. The corresponding progression rates for patients with bilateral background retinopathy in successive screening episodes were 13–29% and up to 4%, respectively, in the different programs.
Conclusions: it may be possible to stratify patients for risk, according to baseline retinal criteria, into groups with low and high risk of their conditions progressing to proliferative retinopathy. Screening intervals for such diverse groups of patients could safely be modified according to their risk.
488-494
Leese, Graham P.
f8d47731-6261-44dc-b7ec-00fdd1a23577
Stratton, Irene M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Land, Martin
e83e35a5-2afa-4364-bd4a-5c140e58d531
Bachmann, Max O.
af14ea89-a31a-44e2-84a7-896812875117
Jones, Colin
a40b9156-af90-4bcc-93ce-1a18b0229113
Scanlon, Peter
4e3d2310-c79e-42db-ae29-7a7d6b278aa3
Looker, Helen C.
120eab7e-714c-43b8-a5d8-cd4d8817b88e
Ferguson, Brian
aa2860cc-fea7-45f9-b388-08159c1ce86e
on behalf of the Four Nations Diabetic Retinopathy Screening Study Group
March 2015
Leese, Graham P.
f8d47731-6261-44dc-b7ec-00fdd1a23577
Stratton, Irene M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Land, Martin
e83e35a5-2afa-4364-bd4a-5c140e58d531
Bachmann, Max O.
af14ea89-a31a-44e2-84a7-896812875117
Jones, Colin
a40b9156-af90-4bcc-93ce-1a18b0229113
Scanlon, Peter
4e3d2310-c79e-42db-ae29-7a7d6b278aa3
Looker, Helen C.
120eab7e-714c-43b8-a5d8-cd4d8817b88e
Ferguson, Brian
aa2860cc-fea7-45f9-b388-08159c1ce86e
Leese, Graham P., Stratton, Irene M., Land, Martin, Bachmann, Max O., Jones, Colin, Scanlon, Peter, Looker, Helen C. and Ferguson, Brian
,
on behalf of the Four Nations Diabetic Retinopathy Screening Study Group
(2015)
Progression of diabetes retinal status within community screening programs and potential implications for screening intervals.
Diabetes Care, 38 (3), .
(doi:10.2337/dc14-1778).
Abstract
Objective: this study aimed to follow the natural progression of retinal changes in patients with diabetes. Such information should inform decisions with regard to the screening intervals for such patients.
Research design and methods: an observational study was undertaken linking the data from seven diabetes retinal screening programs across the U.K. for retinal grading results between 2005 and 2012. Patients with absent or background retinopathy were followed up for progression to the end points referable retinopathy and treatable retinopathy (proliferative retinopathy).
Results: in total, 354,549 patients were observed for up to 4 years during which 16,196 patients progressed to referable retinopathy. Of patients with no retinopathy in either eye for two successive screening episodes at least 12 months apart, the conditions of between 0.3% (95% CI 0.3–0.8%) and 1.3% (1.0–1.6%) of patients progressed to referable retinopathy, and rates of treatable eye disease were <0.3% at 2 years. The corresponding progression rates for patients with bilateral background retinopathy in successive screening episodes were 13–29% and up to 4%, respectively, in the different programs.
Conclusions: it may be possible to stratify patients for risk, according to baseline retinal criteria, into groups with low and high risk of their conditions progressing to proliferative retinopathy. Screening intervals for such diverse groups of patients could safely be modified according to their risk.
This record has no associated files available for download.
More information
Accepted/In Press date: 18 November 2014
e-pub ahead of print date: 18 December 2014
Published date: March 2015
Identifiers
Local EPrints ID: 487137
URI: http://eprints.soton.ac.uk/id/eprint/487137
ISSN: 0149-5992
PURE UUID: f414f56d-2dba-49b6-8866-d756263a58a6
Catalogue record
Date deposited: 14 Feb 2024 17:38
Last modified: 18 Mar 2024 04:01
Export record
Altmetrics
Contributors
Author:
Graham P. Leese
Author:
Irene M. Stratton
Author:
Martin Land
Author:
Max O. Bachmann
Author:
Colin Jones
Author:
Peter Scanlon
Author:
Helen C. Looker
Author:
Brian Ferguson
Corporate Author: on behalf of the Four Nations Diabetic Retinopathy Screening Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics